Condition

MCL (1)

Mantle Cell Lymphoma (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Nordic Lymphoma Group (1)

Collaborator

AstraZeneca (1)

Intervention

acalabrutinib-rituximab in patients with untreated mantle cell lymphoma (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

mcl

Showing NaN - NaN of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

MCL, Mantle Cell Lymphoma Trial in Worldwide (Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma)

Recruiting

MCL
Mantle Cell Lymphoma

Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma

Odense, Denmark
+21 more

Feb 11, 2022